Bile Salts Modulate the Mucin-Activated Type VI Secretion System of Pandemic Vibrio cholerae

PLoS Neglected Tropical Diseases
Verena BachmannStefan Pukatzki

Abstract

The causative agent of cholera, Vibrio cholerae, regulates its diverse virulence factors to thrive in the human small intestine and environmental reservoirs. Among this pathogen's arsenal of virulence factors is the tightly regulated type VI secretion system (T6SS). This system acts as an inverted bacteriophage to inject toxins into competing bacteria and eukaryotic phagocytes. V. cholerae strains responsible for the current 7th pandemic activate their T6SS within the host. We established that T6SS-mediated competition occurs upon T6SS activation in the infant mouse, and that this system is functional under anaerobic conditions. When investigating the intestinal host factors mucins (a glycoprotein component of mucus) and bile for potential regulatory roles in controlling the T6SS, we discovered that once mucins activate the T6SS, bile acids can further modulate T6SS activity. Microbiota modify bile acids to inhibit T6SS-mediated killing of commensal bacteria. This interplay is a novel interaction between commensal bacteria, host factors, and the V. cholerae T6SS, showing an active host role in infection.

References

May 1, 1978·Applied and Environmental Microbiology·A Bauernfeind, J R Burrows
Jul 1, 1989·The Journal of Infectious Diseases·T Yamamoto, T Yokota
Mar 1, 1969·The Journal of Infectious Diseases·K ShimadaS M Finegold
Oct 1, 1980·The Journal of Applied Bacteriology·A FerrariE Canzi
Aug 30, 2000·Microbes and Infection·J S Gunn
May 12, 2001·Infection and Immunity·M Sandkvist
Dec 19, 2001·Infection and Immunity·Jamie A WibbenmeyerAnne H Delcour
Apr 2, 2004·Lipids·Timothy Scott WiedmannHeather Herrington
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Deborah T Hung, John J Mekalanos
Jul 14, 2005·Nature Reviews. Microbiology·Susan M Butler, Andrew Camilli
Aug 17, 2005·FEMS Microbiology Reviews·Máire BegleyColin Hill
Dec 17, 2005·Science·Karin L MeibomGary K Schoolnik
Dec 20, 2005·Molecular Microbiology·Deborah T HungJohn J Mekalanos
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefan PukatzkiJohn J Mekalanos
Sep 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ansel HsiaoJun Zhu
Aug 19, 2007·Infection and Immunity·Verena OlivierKarla J Fullner Satchell
Sep 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Stefan PukatzkiJohn J Mekalanos
Nov 8, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mary-Jane LombardoJames B Kaper
Jan 29, 2008·Journal of Bacteriology·Preeti Malik-KaleMichael E Konkel
May 20, 2008·Cellular and Molecular Life Sciences : CMLS·A F Hofmann, L R Hagey
Jul 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Zhi LiuJun Zhu
Sep 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Malin E V JohanssonGunnar C Hansson
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Petr G LeimanJohn J Mekalanos
Feb 13, 2010·Proceedings of the National Academy of Sciences of the United States of America·Amy T Ma, John J Mekalanos
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Malin E V JohanssonGunnar C Hansson
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Dana L MacIntyreStefan Pukatzki
Nov 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jun ZhengJohn J Mekalanos
Mar 17, 2011·Nature Reviews. Microbiology·Michael A McGuckinTimothy H Florin
Aug 17, 2011·Cell Host & Microbe·Anjali MandlikMatthew K Waldor
Nov 3, 2011·PloS One·Benjamin P WillingB Brett Finlay
Nov 16, 2011·Infection and Immunity·Takahiko IshikawaSun Nyunt Wai
Jun 8, 2012·Science·Jeremy K NicholsonSven Pettersson
Jul 7, 2012·Science·M Basler, J J Mekalanos

❮ Previous
Next ❯

Citations

Jan 2, 2016·Current Opinion in Microbiology·Abderrahman HachaniAlain Filloux
Oct 8, 2015·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Melanie Blokesch
Aug 24, 2016·Frontiers in Microbiology·Reed M StubbendieckPaul D Straight
Aug 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Thibault G SanaDenise M Monack
Dec 29, 2016·Trends in Microbiology·Avatar JoshiFitnat H Yildiz
Jul 8, 2016·Nature·Andreas J Bäumler, Vanessa Sperandio
May 19, 2019·Molecular Microbiology·Ronan R McCarthyAlain Filloux
Dec 25, 2019·Cellular Microbiology·Luke P AllsoppAlain Filloux
Mar 7, 2020·Environmental Microbiology·Cristian V Crisan, Brian K Hammer
Nov 30, 2019·MSphere·Ana A WeilJason B Harris
Jul 19, 2019·Frontiers in Microbiology·Can ChenXihui Shen
Jun 16, 2019·Internal and Emergency Medicine·Nooshin DaliliShiva Kalantari
Jun 9, 2017·PLoS Pathogens·Thibault G SanaDenise M Monack
Sep 22, 2018·Science·Leonor García-Bayona, Laurie E Comstock
Mar 19, 2019·Environmental Microbiology·Rotem Ben-Yaakov, Dor Salomon
Jun 20, 2018·Proceedings of the National Academy of Sciences of the United States of America·David FastStefan Pukatzki
Jan 10, 2018·Pathogens and Disease·Kenneth M Peterson, Patrick S Gellings
Sep 30, 2020·Environmental Microbiology·Patricia BernalLuke P Allsopp
Sep 2, 2020·Journal of Bacteriology·Abby FrederickDean A Rowe-Magnus
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Zixin QinZhi Liu
Feb 5, 2021·Scientific Reports·Cristian V CrisanBrian K Hammer
Jul 29, 2016·Clinical Microbiology Reviews·Jeticia R SistrunkChristina S Faherty
Jun 29, 2021·Gut Microbes·Jennifer Y ChoAnsel Hsiao
Aug 9, 2021·Current Opinion in Microbiology·Lara KernEran Elinav
Dec 6, 2017·ACS Infectious Diseases·Abraham J Waldman, Emily P Balskus
Sep 21, 2021·Infection and Immunity·Thomas F BinaJames E Bina

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
RNASeq
super-resolution microscopy

Software Mentioned

CFX Manager
PrimerQuest

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.